Role of dopamine D3 receptors in the expression of conditioned fear in rats

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 167-176

  Swain, Shelley N ^a   Beuk, Jonathan ^a   Heidbreder, Christian A ^b   Beninger, Richard J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b GSK   (Italy)

Author keywords

BP 897; Conditioning; D3 receptors; Dopamine; Fear; SB 277011A

Indexed keywords

BP 897; DOPAMINE 2 RECEPTOR; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; DOPAMINE 3 RECEPTOR; NITRILE; PIPERAZINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; FEAR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULATION; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; ELECTRIC SHOCK; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; FEAR; MALE; NITRILES; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D3; TETRAHYDROISOQUINOLINES;

EID: 37549018584     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.011     Document Type: Article

References (46)

1. 3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28 (2003) 1272-1280
2. 3 receptor antagonist SB-277011-A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 48 (2003) 154-156
3. 3 receptor partial agonist, BP 897, block intra-NAC amphetamine conditioned activity. Behav. Neurosci. 118 (2004) 1324-1330
4. 3 receptor-preferring partial agonist BP897 dose-dependently attenuates the expression of amphetamine-conditioned place preference. Behav. Pharmacol. 16 (2005) 181-186
5. 3 receptor partial agonist blocks the expression of conditioned activity. NeuroReport 13 (2002) 173-176
6. Bouton M.E. Context and behavioral processes in extinction. Learn. Mem. 11 (2004) 485-494
7. 3 receptors by SB277011A, NGB2904 or BP897 attenuates nicotine-enhanced brain stimulation reward in rat. Abstracts of the 34th Annual Meeting of the Society for Neuroscience, 2004 Abstract Viewer/Itinerary Planner, (abstract 691.6) Washington, DC. (2004)
8. 3 and D2 dopamine receptors. Neuropsychopharmacology 28 (2003) 1150-1159
9. 3 receptors attenuates cocaine-seeking behaviour in the rat. Int. J. Neuropsychopharmacology (2006) 1-15 Jan 23, (Electronic publication ahead of print)
10. 3 receptor partial agonist, BP 897, is a potent ligand at diverse adrenergic and serotonergic receptors. Abstr. - Soc. Neurosci. 26 (2000) 2154
11. Davis M., Walker D.C., and Myers K.M. Role of the amygdala in fear extinction measured with fear-potentiated startle. Ann. N.Y. Acad. Sci. 985 (2003) 218-232
12. De Fonseca F.R., Rubio P., Martin-Calderon J.L., Caine S.B., Koob G.F., and Navarro M. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274 (1995) 47-55
13. 3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28 (2003) 329-338
14. 3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology 28 (2003) 1903-1915
15. 3 in morphine-induced conditioned place preference using drd3-knockout mice. NeuroReport 15 (2004) 2245-2249
16. Fyer A.J. Current approaches to etiology and pathophysiology of specific phobia. Biol. Psychiatry 44 (1998) 1295-1304
17. 3 receptors. Synapse 57 (2005) 17-28
18. Greba Q., Gifkins A., and Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res. 899 (2001) 218-226
19. 2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav. Neurosci. 114 (2000) 647-651
20. 3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. NeuroReport 14 (2003) 93-98
21. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Rev. 49 (2005) 77-105
22. Inoue T., Izumi T., Maki Y., Muraki I., and Koyama T. Effect of dopamine D1/5 antagonist SCH 23390 on the acquisition of conditioned fear. Pharmacol. Biochem. Behav. 66 (2000) 573-578
23. Jaber M., Robinson S.W., Missale C., and Caron M.G. Dopamine receptors and brain function. Neuropharmacology 35 (1996) 1503-1519
24. Khroyan T.V., Baker D.A., Fuchs R.A., Manders N., and Neisewander J.L. Differential effects of 7-OH-DPAT on amphetamine-induced stereotypy and conditioned place preference. Psychopharmacology 139 (1998) 332-341
25. 3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Neuropsychopharmacology 28 (2003) 839-849
26. 3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without acetylcholinesterases. J. Neurosci. Methods 157 (2006) 25-31
27. 3 receptor antagonists improve the learning performance of memory-impaired rats. Psychopharmacology (Berl.) 179 (2005) 567-575
28. 3 receptor in reactivity to cocaine-associated cues in mice. Eur. J. Neurosci. 15 (2002) 2016-2026
29. 3 receptor ligands. Mol. Psychiatry 8 (2003) 225-230
30. 3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30 (2005) 720-730
31. LeDoux J. Emotion circuits in the brain. Annu. Rev. Neurosci. 23 (2000) 155-184
32. 3 receptor antagonists: a review 2001-2005. Recent Patents CNS Drug Disc 1, 271-288.
33. 3 versus D2 receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. J. Neurochem. 100 (2007) 1047-1061
34. Overton D.A. Basic mechanisms of state-dependent learning. Psychopharmacol. Bull. 14 (1978) 67-68
35. 3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int. J. Neuropsychopharmacol. 9 (2006) 585-602
36. Papp M., Gruca P., and Willner P. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA receptor antagonist. Neuropsychopharmacology 27 (2002) 727-743
37. 3 receptor agonist. Nature 400 (1999) 371-375
38. 3 receptor antagonist, SB-277011-A. J. Pharmacol. Exp. Ther. 294 (2000) 1154-1165
39. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A.H. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol. Biochem. Behav. 74 (2002) 187-197
40. Robbins T.W. Behavioral determinants of drug action: rate-dependency revisited. In: Cooper S.J. (Ed). Theory in Psychopharmacology 1 (1981), Academic Press Inc, London, UK 1-63
41. 3 receptor antagonist with high oral bioavailability and CNS penetration in the rat. J. Med. Chem. 43 (2000) 1878-1885
42. Suzuki T., Ishigooka J., Watanabe S., and Miyaoka H. Enhancement of delayed release of dopamine in the amygdala induced by conditioned fear stress in methamphetamine-sensitized rats. Eur. J. Pharmacol. 435 (2002) 59-65
43. 3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J. 20 (2006) 2223-2233
44. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22 (2002) 9595-9603
45. 3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 176 (2004) 57-65
46. 3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur. J. Neurosci. 21 (2005) 3427-3438